Beijing Labtech Instruments Co., Ltd.

SSE:688056.SS

34.46 (CNY) • At close May 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12015 Q22015 Q1
Revenue 99.051112.91797.006107.986104.745116.045103.6999.66196.599105.97593.51378.03677.48100.06786.637102.60979.545123.47686.36293.98244.784128.25585.703115.26851.29248.67448.674
Cost of Revenue 54.49159.39153.11160.65560.367.57659.42854.92751.89658.50748.00639.6339.49355.10341.43953.41340.23865.05243.61570.47522.48370.96543.79989.5344.99122.63422.634
Gross Profit 44.5653.52643.89447.33144.44548.4744.26244.73444.70347.46845.50738.40637.98844.96545.19849.19639.30758.42542.74723.50722.30157.2941.90525.7386.30226.0426.04
Gross Profit Ratio 0.450.4740.4520.4380.4240.4180.4270.4490.4630.4480.4870.4920.490.4490.5220.4790.4940.4730.4950.250.4980.4470.4890.2230.1230.5350.535
Reseach & Development Expenses 11.35813.28513.02411.06812.34815.35915.13911.71810.00111.4419.8818.2778.8038.478.8076.457.65610.3776.5036.0926.37110.3146.3914.5734.5732.1512.151
General & Administrative Expenses 7.295-10.27115.511-1.4177.174-9.40116.203-1.4567.459-8.6713.682-1.35.944-8.10211.9430.5644.318-5.5614.5184.6474.58-7.5585.2734.7574.7576.2446.244
Selling & Marketing Expenses 15.175-36.0441.89517.56215.98819.38418.54517.63716.51416.62415.09514.15512.69314.59513.03513.48312.15213.78512.9819.6629.8714.11615.11413.32713.32710.52210.522
SG&A 22.47-46.31257.67225.16623.4139.98334.74816.18123.9737.95328.77812.85518.6376.49324.97814.04716.478.22417.49915.55714.3746.55720.38718.49718.49717.12817.128
Other Expenses -3.67980.65-5.330.325-0.17-0.016-0.0160.003-0.4715.897-7.0097.4610.4522.1192.680.1080.02410.9180.2450.658-42.9720.14-0.0172.322-48.25400
Operating Expenses 30.14947.62431.34435.90935.93141.9841.60236.73933.50435.29231.6528.59427.89129.85528.04126.83324.55431.34424.3840.658-42.97229.65527.5392.322-48.25417.33317.333
Operating Income 14.4115.90312.39511.4228.5142.0723.0979.57613.72112.4419.44311.6358.40115.93419.84823.39417.80424.67418.57524.1651.81227.43514.9828.063.0398.4798.479
Operating Income Ratio 0.1450.0520.1280.1060.0810.0180.030.0960.1420.1170.2080.1490.1080.1590.2290.2280.2240.20.2150.2570.040.2140.1750.2430.0590.1740.174
Total Other Income Expenses Net -0.01-0.0250.0292.7382.022-0.016-0.0160.0032.587-0.17-0.0121.8762.4492.1194.9561.3562.7498.8190.2450.093-1.9690.3590.7710.031-0.0050.5960.596
Income Before Tax 14.4025.87812.42414.1611.2752.0563.0819.57813.71912.2714.10911.74313.06918.05322.59123.43917.82833.49218.8224.258-0.15727.57514.96328.093.0349.0749.074
Income Before Tax Ratio 0.1450.0520.1280.1310.1080.0180.030.0960.1420.1160.1510.150.1690.180.2610.2280.2240.2710.2180.258-0.0030.2150.1750.2440.0590.1860.186
Income Tax Expense 1.6351.8261.1691.894-0.31.155-0.751-0.3820.8512.1681.6851.5611.1542.2143.2743.6333.3774.4822.04846.849-42.8095.2811.45653.654-48.5061.9351.935
Net Income 12.7674.05211.25612.26611.5750.9023.8329.96112.86810.10212.42510.18311.91516.09119.23119.55714.53528.94116.70319.887-0.3221.94313.51322.5823.2867.1397.139
Net Income Ratio 0.1290.0360.1160.1140.1110.0080.0370.10.1330.0950.1330.130.1540.1610.2220.1910.1830.2340.1930.212-0.0070.1710.1580.1960.0640.1470.147
EPS 0.190.0610.180.180.170.0210.0570.150.190.150.190.150.180.240.290.30.220.520.30.36-0.010.440.270.450.0660.150.15
EPS Diluted 0.190.0610.180.180.170.0210.0570.150.190.150.190.150.180.240.290.30.220.520.30.36-0.010.440.270.450.0660.150.15
EBITDA 14.4255.91312.46118.30915.4676.0827.07612.9717.11414.74619.02914.10110.09720.7413.00524.96217.533.49319.54525.388-0.14227.57814.96416.26416.2649.3679.367
EBITDA Ratio 0.1460.0520.1280.170.1480.0520.0680.130.1770.1390.2030.1810.130.2070.150.2430.220.2710.2260.27-0.0030.2150.1750.1410.3170.1920.192